<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03610815</url>
  </required_header>
  <id_info>
    <org_study_id>7493</org_study_id>
    <nct_id>NCT03610815</nct_id>
  </id_info>
  <brief_title>Community I-STAR Mozambique: Community Implementation of SBIRT Using Technology for Alcohol Use Reduction in Mozambique</brief_title>
  <official_title>Community I-STAR Mozambique: Community Implementation of SBIRT Using Technology for Alcohol Use Reduction in Mozambique</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>New York State Psychiatric Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Columbia University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>New York State Psychiatric Institute</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hazardous drinking (HD) is a major public health burden worldwide with significant morbidity&#xD;
      and mortality. To reduce HD, the World Health Organization (WHO) recommends using Screening,&#xD;
      Brief Intervention, Referral to Treatment (SBIRT). Mobile health technology (mHealth), such&#xD;
      as the mSBIRT app, is a promising tool for widespread cost-effective delivery of&#xD;
      evidence-based HDS by community health workers (CHWs) because of its potential to increase&#xD;
      fidelity, effectiveness, and sustainability. Community I-STAR Mozambique comprises three&#xD;
      phases: 1) mSBIRT adaptation, 2) a cluster-randomized trial, and 3) scale-up of the most&#xD;
      cost-effective intervention. Community I-STAR Mozambique will scale-up a cost effective,&#xD;
      sustainable program and inform policy applicable to Mozambique and other LMICs.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hazardous drinking (HD) is a major public health burden worldwide with significant morbidity&#xD;
      and mortality. The prevention and treatment gap associated with this global burden requires&#xD;
      that efficacious interventions be scaled-up, leveraging existing platforms and participation&#xD;
      of policy makers ready to apply and sustain evidence-informed policies over time. To reduce&#xD;
      HD, the WHO recommends using Screening, Brief Intervention, Referral to Treatment (SBIRT) and&#xD;
      the mental health Gap Action Programme guidelines (mhGAP). As low- and middle-income&#xD;
      countries (LMIC) embrace SBIRT and mhGAP for community based HD services (HDS), a main&#xD;
      scale-up challenge is ensuring effectiveness, fidelity, and sustainability of services.&#xD;
      Mobile health technology (mHealth), such as the mSBIRT app, is a promising tool for&#xD;
      widespread cost-effective delivery of evidence-based HDS by community health workers (CHWs)&#xD;
      because of its potential to increase fidelity, effectiveness, and sustainability. The&#xD;
      proposed project, Community I-STAR (Implementation of SBIRT using Technology for Alcohol use&#xD;
      Reduction) Mozambique, will leverage the following existing Mozambique Ministry of Health&#xD;
      (MoH) programs: (1) a task-shifting strategy training psychiatric technicians (PsyTs) to use&#xD;
      the mhGAP; (2) the WHO-funded epilepsy community program delivered by CHWs; and (3) an&#xD;
      mHealth program for malaria, pneumonia, and diarrhea (inSCALE - Innovations at Scale for&#xD;
      Community Access and Lasting Effects). These currently operating programs set the stage for&#xD;
      the use of mSBIRT by CHWs to deliver community HDS in Mozambique and generate policy for&#xD;
      scale-up of government-funded community HDS harnessing existing human resources. Community&#xD;
      I-STAR Mozambique comprises three phases: 1) mSBIRT adaptation, 2) a cluster-randomized&#xD;
      trial, and 3) scale-up of the most cost-effective intervention. A formative phase to adapt&#xD;
      mSBIRT to Mozambique's context/culture, will be followed by a 2-year, cluster-randomized,&#xD;
      hybrid effectiveness-implementation type 2 trial in 12 districts: 6 districts randomized to&#xD;
      receive mSBIRT and 6 to an SBIRT Conventional Training and Supervision strategy (SBIRT-CTS),&#xD;
      with both arms delivered by CHWs. The arm showing higher cost-effectiveness in the 2-year&#xD;
      trial will be scaled up to the other 6 districts for 12 &quot;cross-over&quot; months. Throughout the&#xD;
      trial and the &quot;cross-over&quot; scale-up, qualitative and process data will complement&#xD;
      quantitative assessments to examine implementation, sustainability, and scale-up. This&#xD;
      approach redefines work roles without requiring new human resources, and it comports with the&#xD;
      MoH's commitment to implementing HDS. Evidence-based practices (SBIRT) will a) build capacity&#xD;
      for complete task-shifting of sustainable community-HDS practices; and b) use implementation&#xD;
      tools to examine implementation and effectiveness of two SBIRT delivery strategies followed&#xD;
      by evaluation of scale-up of the most cost-effective strategy. Community I-STAR Mozambique&#xD;
      will scale-up a cost effective, sustainable program and inform policy applicable to&#xD;
      Mozambique and other LMICs.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2021</start_date>
  <completion_date type="Anticipated">August 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2023</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Effectiveness-Implementation Hybrid 2 Trial</intervention_model_description>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Implementation - Reach</measure>
    <time_frame>From baseline to 6 months</time_frame>
    <description>Number of individual who access care from among those who need care</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical Effectiveness - AUDIT</measure>
    <time_frame>From baseline to 6 months</time_frame>
    <description>Alcohol Use Disorders Identification Test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cost of Implementing New Strategies (COINS)</measure>
    <time_frame>through study completion, an average of 2 years</time_frame>
    <description>Measures cost of implementing interventions</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">540</enrollment>
  <condition>mSBIRT - Mobile Screening, Brief Intervention, Referral to Treatment</condition>
  <condition>SBIRT-CTS - Screening, Brief Intervention, Referral to Treatment Conventional Training and Supervision Strategy</condition>
  <arm_group>
    <arm_group_label>mSBIRT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Mobile Screening, Brief Intervention, Referral to Treatment (mSBIRT)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SBIRT-CTS),</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Screening, Brief Intervention, Referral to Treatment Conventional Training and Supervision strategy</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Screening, Brief Intervention, Referral to Treatment</intervention_name>
    <description>Screening, Brief Intervention, Referral to Treatment</description>
    <arm_group_label>SBIRT-CTS),</arm_group_label>
    <arm_group_label>mSBIRT</arm_group_label>
    <other_name>Motivational Interviewing</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Community Health Workers working in the randomized clinics, Portuguese speakers&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Other clinic staff from this clinics or other clinics&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Milton L Wainberg, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>New York State Psychiatric Institute</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Milton L Wainberg, MD</last_name>
    <phone>6467746430</phone>
    <email>mlw35@cumc.columbia.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>MIHER: Mozambique Institute for Health Education and Research</name>
      <address>
        <city>Maputo</city>
        <zip>1101</zip>
        <country>Mozambique</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alcido Nguenha</last_name>
      <phone>+254213180</phone>
      <email>info@miher.org</email>
    </contact>
  </location>
  <location_countries>
    <country>Mozambique</country>
  </location_countries>
  <reference>
    <citation>Morgenstern J, Irwin TW, Wainberg ML, Parsons JT, Muench F, Bux DA Jr, Kahler CW, Marcus S, Schulz-Heik J. A randomized controlled trial of goal choice interventions for alcohol use disorders among men who have sex with men. J Consult Clin Psychol. 2007 Feb;75(1):72-84.</citation>
    <PMID>17295566</PMID>
  </reference>
  <reference>
    <citation>Irwin TW, Morgenstern J, Parsons JT, Wainberg M, Labouvie E. Alcohol and sexual HIV risk behavior among problem drinking men who have sex with men: An event level analysis of timeline followback data. AIDS Behav. 2006 May;10(3):299-307.</citation>
    <PMID>16482407</PMID>
  </reference>
  <reference>
    <citation>Elliott JC, Aharonovich E, O'Leary A, Wainberg M, Hasin DS. Drinking motives as prospective predictors of outcome in an intervention trial with heavily drinking HIV patients. Drug Alcohol Depend. 2014 Jan 1;134:290-295. doi: 10.1016/j.drugalcdep.2013.10.026. Epub 2013 Nov 5.</citation>
    <PMID>24286967</PMID>
  </reference>
  <reference>
    <citation>Elliott JC, Aharonovich E, O'Leary A, Wainberg M, Hasin DS. Drinking motives among HIV primary care patients. AIDS Behav. 2014 Jul;18(7):1315-23. doi: 10.1007/s10461-013-0644-4.</citation>
    <PMID>24165984</PMID>
  </reference>
  <reference>
    <citation>Hasin DS, Aharonovich E, O'Leary A, Greenstein E, Pavlicova M, Arunajadai S, Waxman R, Wainberg M, Helzer J, Johnston B. Reducing heavy drinking in HIV primary care: a randomized trial of brief intervention, with and without technological enhancement. Addiction. 2013 Jul;108(7):1230-40. doi: 10.1111/add.12127. Epub 2013 Apr 17.</citation>
    <PMID>23432593</PMID>
  </reference>
  <reference>
    <citation>Aharonovich E, Hatzenbuehler ML, Johnston B, O'Leary A, Morgenstern J, Wainberg ML, Yao P, Helzer JE, Hasin DS. A low-cost, sustainable intervention for drinking reduction in the HIV primary care setting. AIDS Care. 2006 Aug;18(6):561-8.</citation>
    <PMID>16831783</PMID>
  </reference>
  <reference>
    <citation>Oquendo MA, Duarte C, Gouveia L, Mari JJ, Mello MF, Audet CM, Pinsky I, Vermund SH, Mocumbi AO, Wainberg ML. Building capacity for global mental health research: challenges to balancing clinical and research training. Lancet Psychiatry. 2018 Aug;5(8):612-613. doi: 10.1016/S2215-0366(18)30097-X. Epub 2018 Apr 5.</citation>
    <PMID>29628365</PMID>
  </reference>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>June 24, 2018</study_first_submitted>
  <study_first_submitted_qc>July 25, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 1, 2018</study_first_posted>
  <last_update_submitted>October 29, 2021</last_update_submitted>
  <last_update_submitted_qc>October 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>New York State Psychiatric Institute</investigator_affiliation>
    <investigator_full_name>Milton L. Wainberg, MD</investigator_full_name>
    <investigator_title>Research Scientist</investigator_title>
  </responsible_party>
  <keyword>Alcohol</keyword>
  <keyword>SBIRT</keyword>
  <keyword>Mobile Technology</keyword>
  <keyword>Implementation Science</keyword>
  <keyword>Dissemination Research</keyword>
  <keyword>Hybrid Effectiveness-Implementation Design</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alcohol Drinking</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Investigators will use the Global Mental Health Program at Columbia University (GMHP@CU) to make data available requiring acknowledgement of the the source of data and anonymity of research participants. Public codebooks and analysis protocols will be available.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>3 years after study completion</ipd_time_frame>
    <ipd_access_criteria>Described above in the plan description</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

